Veterinary Medicines

Fevaxyn Quatrifel

Not authorised
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
Download as PDF

Product identification

Medicine name:
Fevaxyn Quatrifel
Active substance:
  • Chlamydia felis, strain Cello, Inactivated
  • Feline panleucopenia virus, strain CU4, Inactivated
  • Feline calicivirus, strain 255, Inactivated
  • Felid herpesvirus 1, strain 605, Inactivated
Target species:
  • Cat
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Chlamydia felis, strain Cello, Inactivated
    1.69
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Feline panleucopenia virus, strain CU4, Inactivated
    8.50
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Feline calicivirus, strain 255, Inactivated
    1.26
    relative unit(s)
    /
    1.00
    millilitre(s)
  • Felid herpesvirus 1, strain 605, Inactivated
    1.39
    relative unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AL02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Germany
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Paul-Ehrlich-Institut
Authorisation number:
  • 190a/94
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 24/02/2022
Download